GEN - Genetic Engineering and Biotechnology News
Feb 1, 2013 (Vol. 33, No. 3)
Tying Up Loose Ends in Cell-Line Development
by Angelo DePalma, Ph.D. NovelExpression Methodology
Genome-editing technologies now permit precise positioning of deletions, modifications, and
transgenes within living cells. These ideas have led Zsolt Keresztessy, Ph.D., senior research fellow at Proxencell, to a method employing sequence-specific meganucleases and TAL effector nucleases to generate stable monoclonal cell lines expressing membrane-bound antigens, FCGR receptors, and monoclonal antibodies. TAL effector nucleases are novel sequence-specific nucleases, formed by fusing a transcription activator-like (TAL) effector DNA binding domain to the catalytic head of an endonuclease. As a core facility for the University of Debrecen in Hungary, Proxencell provides
protein expression services using optimized synthetic genes and expression organisms that include bacteria, yeast, and both insect and mammalian cells for small- and large-scale protein production. Dr. Keresztessy explains that specific genome editing technologies are still in the
initial evolutionary phase—true especially for TAL effector nucleases. “That means, in addition to requiring substantial optimization work, investigators must also innovate in the adaptation of commercially available systems from, for example, Cellectis Bioresearch or Life Technologies.” Uncovering effective ways to transfer and express sequence-specific nucleases (e.g.,
plasmid DNA, mRNA, or proteins) into your target cells or cell lines, together with accessory sequences including like templates for homologous recombination or genome editing reporter constructs, is critical. “As a result, we were forced to develop new technologies for assessing genome
modifications at early stages of TAL transfections, strategies and tools for detecting and enriching knockout cells, and new approaches for mapping TAL specificity in vivo in automated and high-throughput assays.” Dr. Keresztessy and colleagues have enjoyed several successes in designing
bioassay-worthy cells through these strategies. More relevant here are production cells. When the goal is overexpressing a protein—for example, a monoclonal antibody—for large-scale production, a variety of choices exist from commercially available reagent kits. Dr. Keresztessy’s system of choice is the cGPS CHO-Sa CEMAX system from Cellectis. “However, we needed to construct our own version of the integration matrix vector
provided by the vendor to efficiently express our mutant therapeutic antibodies, which we aimed to use as cellular assay controls in our research applications. Into the vector, we cloned the synthetic genes of the light and heavy chains of a human IgG framework, with the desired mutations, linked via an in-house designed and optimized IRES sequence.” |
Menu
Links & Partnes
Links & Partners
Magyar Gazdaságfejlesztési Központ
Center for Clinical Genomics and Personalised medicine
Nuclear Hormon Receptor Research Laboratory - NLAB
Department of Biochemistry and Molecular Biology
Medical and Health Science Center
Research Center for Molecular Medicine
UD-GenoMed Medical Genomic Technologies Ltd
Customers' Wishlist
I need
... a custom stable cell line!
... purified recombinant proteins!
... a custom monoclonal antibody!
... cytokines for my research!
... engineered proteins!
... a protein with novel functions!
Contact PROXENCELL
Dr. Zsolt Keresztessy, PhD MBA
Protein Expression and Cell Engineering Laboratory
Center for Clinical Genomics and Personalised Medicine
Nagyerdei krt 98, Debrecen H-4032 Hungary
Tel: +36 52 411 717 / 50226, 50206
e-mail: zsolt.keresztessy@med.unideb.hu
Find us:
Room 3.2.5 and Lab3.26, IVDI Building, Medical and Health Sciences Center
ORDERING INFO: LINK
News
Protein Expression Services
Protein expression services are opening for the University of Debrecen from May 2012.
Recombinant Human IL-4
Recombinant human IL-4 is available for purchase either in the form of IL-4 containing culture medium (use 1:10 dilution) or in purified form. The protein is produced in HEK293T cells, batch-tested by Western blotting, ELISA, TF-1 proliferation assay, and against endotoxins. See product sheet. Please, order online.
Polyclonal anti-SMRT antibody
Rabbit polyclonal anti-SMRT antibody is available for purchase. The antibody is protein-A purified, Western, IP, IHC, ChIP tested. See product sheet.
Gene-to-Protein Services
We deliver full service from custom DNA sequence to purified recombinant protein. Individually available service components are cloning, expression, purification, and characterisation of your protein of interest.
Stable Cell Line Development
We offer state-of-the-art Cell and Genome Engineering technologies to generate custom stable cell lines for research, bioassays and protein production. Site-specific gene mutations, deletions, insertions, gene insertions, multiple transgenic cell lines.
Monoclonal antibody development
You provide a custom target sequence – we produce specific mouse monoclonal antibodies.
Epitope design, peptide synthesis, immunisation, hybridoma generation and screening, antibody production, purification and characterisation.
Cytokine Development Services
If you need a cytokine at an affordable price for your research - we produce it for you. The workflow includes gene design and optimisation, gene synthesis, cloning into expression vectors, expression, purification and biochemical/biological characterisation of your recombinant cytokines.
Recombinant proteins
We offer special services and consultation in the field of custom recombinant protein development, engineering, design, and evolution, including mutagenesis, library generation, directed molecular evolution, phage display technology, HTS screening.
Antibodies and cytokines at great prices
Cytokine products:
human IL-4, IL-2, GM-CSF,
mouse IL-4
Coming soon: LIF, IL-9, IL-15